Checkmate Pharmaceuticals, Inc Checkmate (NASDAQ: CMPI) Announces its Acquisition by Regeneron Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) disclosed that it has inked a definitive agreement for the purchase of Checkmate by Regeneron at an all-cash price
